Home › Funds › Ensign Peak Advisors, Inc › GILD

Ensign Peak Advisors, Inc position in GILD

GILEAD SCIENCES INC · Health Care

Ensign Peak Advisors, Inc reported holding 1,701,502 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$253.6M, representing 0.42% of its reported portfolio and ranking #40 among its reported holdings. Ensign Peak Advisors, Inc has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.70M sh
Reported value held$253.61M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ensign Peak Advisors, Inc's GILD position evolved

Ensign Peak Advisors, Inc first disclosed a stake in GILD in Q3 2023 at 3,578,700 shares (US$268.2M). The position peaked in Q1 2026 at 2,338,222 shares, worth US$325.9M. Across 13 filings, Ensign Peak Advisors, Inc increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,701,502 shares valued at US$253.6M — a reduction of -239,115 shares quarter over quarter.. Notable position changes include a 52% trim in Q1 2024 (shares fell 6% over the following quarter), a 28% increase in Q1 2025 (shares were roughly flat over the following quarter), a 27% trim in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.58M $268.19M New
Q4 2023 2.98M $241.36M Reduce
Q1 2024 1.43M $105.02M Reduce
Q2 2024 1.43M $98.03M Hold
Q3 2024 1.61M $134.93M Add
Q4 2024 1.67M $154.25M Add
Q1 2025 2.15M $240.35M Add
Q2 2025 2.30M $254.75M Add
Q3 2025 2.66M $294.97M Add
Q4 2025 1.94M $237.67M Reduce
Q1 2026 2.34M $325.88M Add
Q2 2026 1.94M $245.18M Reduce
Q3 2026 1.70M $253.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Ensign Peak Advisors, Inc held GILD?

Ensign Peak Advisors, Inc has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ensign Peak Advisors, Inc's current position in GILD?

As of Q3 2026, Ensign Peak Advisors, Inc holds 1.70M shares of GILD (GILEAD SCIENCES INC), valued at $253.61M, representing 0.42% of its reported portfolio and ranking #40.

Has Ensign Peak Advisors, Inc been buying or selling GILD?

In the latest 13F filing (Q3 2026), Ensign Peak Advisors, Inc reduced its position in GILD. The position peaked in Q1 2026 at 2.34M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.